Rheumatoid arthritis Rheumatoid arthritis
Conditions
Interventions
None listed
Sponsors
Mikawa Yasuhito
Murakami Yasufumi
Eligibility
Inclusion criteria
Inclusion criteria: A case report of the use of Korean seed tea in patients whose rheumatoid arthritis was not responding to standard medications
Exclusion criteria
Exclusion criteria: 1) Patients who were unable to continue the study due to hypersensitivity or allergic reactions to Korean seed tea. 2) Patients who are taking other drugs concomitantly, or who have previously participated in clinical trials and have not yet taken the test drug for more than one month. 3) Patients who are otherwise deemed inappropriate by the principal investigator or co-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The progression of rheumatoid arthritis is evaluated using blood test results of rheumatoid factor (RF), anti-CCP antibodies, inflammatory markers (CRP), etc. Effectiveness against pain is measured using an evaluation scale such as VAS (Visual Analogue Scale) to measure overall satisfaction (QOL). | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse event rates are measured using CTCAE. | — |
Contacts
Public ContactHideo Kobayashi
Japan Society of Clinical Study for Frontier-Medicine
Outcome results
None listed